v3.25.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
At September 30, 2025 and 2024 the Common Stock equivalent shares were as follows:

At September 30, 2025 and 2024 the Common Stock equivalent shares were as follows:

 

         
   September 30, 
   2025   2024 
Shares of Common Stock issuable upon exercise of options   361,624    361,624 
Shares of Common Stock issuable upon exercise of warrants   415,974    331,921 
Shares of Common Stock issuable upon conversion of Series B preferred stock   53,096    — 
Shares of Common Stock issuable upon conversion of Series C preferred stock   —    — 
Shares of Common Stock issuable upon exercise of Warrants for Series B preferred stock and subsequent conversion to Common Stock   3,333,319    — 
Common Stock equivalents excluded from diluted net loss per share   4,164,013    693,545